1. Home
  2. CCM vs MLSS Comparison

CCM vs MLSS Comparison

Compare CCM & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCM

Concord Medical Services Holdings Limited

HOLD

Current Price

$4.72

Market Cap

19.0M

Sector

Health Care

ML Signal

HOLD

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.32

Market Cap

22.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCM
MLSS
Founded
1997
1989
Country
China
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
22.1M
IPO Year
2009
1996

Fundamental Metrics

Financial Performance
Metric
CCM
MLSS
Price
$4.72
$0.32
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
42.3K
192.4K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$8,973,982.00
Revenue This Year
N/A
$12.64
Revenue Next Year
N/A
$8.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.99
52 Week Low
$3.18
$0.22
52 Week High
$10.77
$0.69

Technical Indicators

Market Signals
Indicator
CCM
MLSS
Relative Strength Index (RSI) 46.88 44.79
Support Level $4.41 $0.24
Resistance Level $5.63 $0.40
Average True Range (ATR) 0.47 0.03
MACD -0.04 -0.00
Stochastic Oscillator 18.82 34.93

Price Performance

Historical Comparison
CCM
MLSS

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

Share on Social Networks: